Study Challenges FDA on Plavix
… Squibb Co. and Sanofi SA, or an alternative treatment such as Eli Lilly & Co.'s Effient. Its use is considered by some to be a step forward in personalized medicine, the holy grail of clinical care in which treatments are tailored to individuals. …
See all stories on this topic »